{"id":"https://openalex.org/W2105689903","doi":"https://doi.org/10.1128/aac.02664-14","title":"Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy","display_name":"Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy","publication_year":2014,"publication_date":"2014-05-05","ids":{"openalex":"https://openalex.org/W2105689903","doi":"https://doi.org/10.1128/aac.02664-14","mag":"2105689903","pmid":"https://pubmed.ncbi.nlm.nih.gov/24798288","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4068511"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02664-14","doi":"https://doi.org/10.1128/aac.02664-14","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02664-14","pdf_url":"https://aac.asm.org/content/aac/58/7/4094.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://aac.asm.org/content/aac/58/7/4094.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089192790","display_name":"Tim Felton","orcid":"https://orcid.org/0000-0001-6868-6633","observed_orcids":["https://orcid.org/0000-0001-6868-6633"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T. W. Felton","raw_affiliation_strings":["The University of Manchester, Manchester Academic Health Science Centre, NIHR Clinical Research Facility in Respiratory Medicine, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Manchester, Manchester Academic Health Science Centre, NIHR Clinical Research Facility in Respiratory Medicine, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037468542","display_name":"Jason Alexander Roberts","orcid":"https://orcid.org/0000-0001-6218-435X","observed_orcids":["https://orcid.org/0000-0001-6218-435X","https://orcid.org/0000-0003-0268-6723","https://orcid.org/0000-0002-9734-9764"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"J. A. Roberts","raw_affiliation_strings":["Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane and Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane and Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I2799393793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084249121","display_name":"Thomas P. Lodise","orcid":"https://orcid.org/0000-0002-4730-0655","observed_orcids":["https://orcid.org/0000-0002-4730-0655"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. P. Lodise","raw_affiliation_strings":["Albany College of Pharmacy and Health Sciences, Albany, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany College of Pharmacy and Health Sciences, Albany, New York, USA","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110211909","display_name":"M. Van Guilder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Van Guilder","raw_affiliation_strings":["Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001923755","display_name":"Emmanuel Boselli","orcid":"https://orcid.org/0000-0002-4949-3518","observed_orcids":["https://orcid.org/0000-0002-4949-3518"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210123600","display_name":"H\u00f4pital Edouard Herriot","ror":"https://ror.org/02qt1p572","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210123600"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Boselli","raw_affiliation_strings":["Department of Anaesthesiology and Intensive Care, \u00c9douard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anaesthesiology and Intensive Care, \u00c9douard Herriot Hospital, Hospices Civils de Lyon, Lyon, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4210123600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026635936","display_name":"Michael Noel Neely","orcid":"https://orcid.org/0000-0002-1675-8276","observed_orcids":["https://orcid.org/0000-0002-1675-8276"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. N. Neely","raw_affiliation_strings":["Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057302419","display_name":"William W. Hope","orcid":"https://orcid.org/0000-0001-6187-878X","observed_orcids":["https://orcid.org/0000-0001-6187-878X"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"W. W. Hope","raw_affiliation_strings":["Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5057302419"],"corresponding_institution_ids":["https://openalex.org/I146655781"],"apc_list":null,"apc_paid":null,"fwci":5.3328,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.96159715,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"58","issue":"7","first_page":"4094","last_page":"4102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/piperacillin","display_name":"piperacillin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.8889999985694885},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.871999979019165},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.5699999928474426},{"id":"https://openalex.org/keywords/bayesian-estimation","display_name":"Bayesian estimation","score":0.5730000138282776},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.9340000152587891},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.9390000104904175},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.9210000038146973},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.75}],"concepts":[{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.9512407779693604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6590797305107117},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6473091244697571},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.5140773057937622},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5068557858467102},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.4872395098209381},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.42973482608795166},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3335420489311218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33239316940307617},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32900190353393555},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.30854904651641846},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09381887316703796},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077725","descriptor_name":"Piperacillin, Tazobactam Drug Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D001499","descriptor_name":"Bayes Theorem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004360","descriptor_name":"Drug Therapy, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010397","descriptor_name":"Penicillanic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010878","descriptor_name":"Piperacillin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016638","descriptor_name":"Critical Illness","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D054796","descriptor_name":"Drug Dosage Calculations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1128/aac.02664-14","doi":"https://doi.org/10.1128/aac.02664-14","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02664-14","pdf_url":"https://aac.asm.org/content/aac/58/7/4094.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3059165","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4068511","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4068511","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4068511","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:24798288","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24798288","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/7941b584-3c21-4202-97d3-f78f6190f103","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/7941b584-3c21-4202-97d3-f78f6190f103","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Felton, T W, Roberts, J, Lodise, T P, Van Guilder, M, Boselli, E, Neely, M N & Hope, W W 2014, 'Individualization of piperacillin dosing for critically ill patients : dosing software to optimize antimicrobial therapy', Antimicrobial Agents and Chemotherapy, vol. 58, no. 7, pp. 4094\u20134102. https://doi.org/10.1128/AAC.02664-14, https://doi.org/10.1128/AAC.02664-14","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1128/aac.02664-14","doi":"https://doi.org/10.1128/aac.02664-14","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02664-14","pdf_url":"https://aac.asm.org/content/aac/58/7/4094.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1435053517","display_name":"Goal-oriented and model-based pharmokinetic dosing of voriconazole in immunocompromised patients","funder_award_id":"CS/08/08/10","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G1549063741","display_name":"Population Pharmacokinetic Modeling and Dual Optimal Control","funder_award_id":"R01GM068968","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G8309072076","display_name":"Ontogeny of Voriconazole Pharmaockinetics and Metabolism","funder_award_id":"R01HD070886","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337611","display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","ror":"https://ror.org/04byxyr05"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2105689903.pdf"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W182687029","https://openalex.org/W1550111394","https://openalex.org/W1561900493","https://openalex.org/W1967088772","https://openalex.org/W1969475605","https://openalex.org/W1969586568","https://openalex.org/W1978397220","https://openalex.org/W1993397663","https://openalex.org/W1995564041","https://openalex.org/W1998410651","https://openalex.org/W2011269667","https://openalex.org/W2016888150","https://openalex.org/W2021298363","https://openalex.org/W2023392621","https://openalex.org/W2054938569","https://openalex.org/W2057939341","https://openalex.org/W2068236756","https://openalex.org/W2079691262","https://openalex.org/W2085150747","https://openalex.org/W2093162201","https://openalex.org/W2093796184","https://openalex.org/W2110278996","https://openalex.org/W2111421292","https://openalex.org/W2111882203","https://openalex.org/W2112401566","https://openalex.org/W2112943695","https://openalex.org/W2113717321","https://openalex.org/W2122344502","https://openalex.org/W2143024482","https://openalex.org/W2145577370","https://openalex.org/W2148103762","https://openalex.org/W2148706534","https://openalex.org/W2153997139","https://openalex.org/W2162857158","https://openalex.org/W2169044544","https://openalex.org/W2582743722"],"related_works":["https://openalex.org/W4323565252","https://openalex.org/W7124229294","https://openalex.org/W7204625626","https://openalex.org/W4405016634","https://openalex.org/W4221105076","https://openalex.org/W2807591339","https://openalex.org/W2571552493","https://openalex.org/W4416815677","https://openalex.org/W4226238115","https://openalex.org/W2778135811"],"abstract_inverted_index":{"Piperacillin-tazobactam":[0],"is":[1,19,268,281],"frequently":[2],"used":[3,37],"for":[4,62,187,238,254],"empirical":[5],"and":[6,68,88,94,156,183,190],"targeted":[7],"therapy":[8],"of":[9,52,73,122,140,143,161,171,192,218,228,233,244,250,272],"infections":[10],"in":[11,21,64,76,115,221,277],"critically":[12,22,65,106,256],"ill":[13,23,66,107,257],"patients.":[14,24],"Considerable":[15],"pharmacokinetic":[16],"(PK)":[17],"variability":[18],"observed":[20,198,206],"By":[25],"estimating":[26],"an":[27,248],"individual's":[28],"PK,":[29],"dosage":[30,155,217,274],"optimization":[31,79,136,211,275],"Bayesian":[32],"estimation":[33],"techniques":[34],"can":[35],"be":[36],"to":[38,44,56,101],"calculate":[39],"the":[40,71,74,77,102,116,128,134,141,152,162,167,197,209,222,234,273],"appropriate":[41],"piperacillin":[42,63,154,164,207,216,226,236,245,260,266],"regimen":[43],"achieve":[45],"desired":[46],"drug":[47,188],"exposure":[48],"targets.":[49],"The":[50,138],"aim":[51],"this":[53],"study":[54],"was":[55,145,148],"establish":[57],"a":[58,176,214,263,278],"population":[59,129],"PK":[60],"model":[61,75,130,179],"patients":[67,108,224],"then":[69],"analyze":[70],"performance":[72],"dose":[78,135,210],"software":[80,212,276],"program":[81],"BestDose.":[82],"Linear,":[83],"with":[84,109,127,180],"estimated":[85],"creatinine":[86,181],"clearance":[87,178,182,189],"weight":[89,184],"as":[90,185],"covariates,":[91],"Michaelis-Menten":[92],"(MM)":[93],"parallel":[95],"linear/MM":[96],"structural":[97],"models":[98],"were":[99,131,202],"fitted":[100],"data":[103],"from":[104,120,166],"146":[105],"nosocomial":[110],"infection.":[111],"Piperacillin":[112],"concentrations":[113,165,237],"measured":[114],"first":[117],"dosing":[118,246],"interval,":[119],"each":[121],"8":[123,223,239],"additional":[124],"individuals,":[125],"combined":[126],"embedded":[132],"into":[133],"software.":[137],"impact":[139],"number":[142],"observations":[144],"assessed.":[146],"Precision":[147],"assessed":[149],"by":[150,157],"(i)":[151],"predicted":[153,213],"(ii)":[158],"linear":[159,177],"regression":[160,232],"observed-versus-predicted":[163,235],"second":[168],"24":[169,242],"h":[170,243],"treatment.":[172],"We":[173],"found":[174],"that":[175],"covariates":[186],"volume":[191],"distribution,":[193],"respectively,":[194],"best":[195],"described":[196],"data.":[199],"When":[200],"there":[201],"at":[203],"least":[204],"two":[205],"concentrations,":[208],"mean":[215],"4.02":[219],"g":[220],"administered":[225],"doses":[227],"4.00":[229],"g.":[230],"Linear":[231],"individuals":[240],"after":[241],"demonstrated":[247],"r(2)":[249],">0.89.":[251],"In":[252],"conclusion,":[253],"most":[255],"patients,":[258],"individualized":[259],"regimens":[261],"delivering":[262],"target":[264],"serum":[265],"concentration":[267],"achievable.":[269],"Further":[270],"validation":[271],"clinical":[279],"trial":[280],"required.":[282]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}